In a regulatory filing, Vera Therapeutics disclosed that its director Patrick Enright bought 1.7M shares of common stock on February 6th in a total transaction size of $12.0M. Shares of Vera Therapeutics were up 3.6% afterhours at $7.50.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on VERA:
- Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock
- Three new option listings and one option delisting on February 2nd
- Vera Therapeutics 14.286M share Spot Secondary priced at $7.00
- Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
- Vera Therapeutics Announces Commencement of Public Offering of Class A Common Stock